The quality of the Discovery Summit 2013 is a direct result of its exclusivity. Participation at the summit is by invitation only, which enables marcus evans to guarantee the quality and networking value of the executive level delegation. Registration is strictly limited to ensure the highest level of interaction between delegates and sponsors.

Delegates will include senior executives from the world’s leading pharma and biotech companies with responsibility in the following areas:

• R&D
• Informatics
• Biologics
• HTS
• Licensing
• Molecular Biology
• Structural Biology
• Toxicology
• Pharmacology
• Lead Generation
• Bioinformatics
• Genomics
• Antibody Engineering
• Medicinal Chemistry